Therapeutic Solutions International Inc (TSOI)

[centsability4me]

MemoryMune
-one of the products in the Emvolio Pipeline

http://emvolio.com/?page_id=133



StemVacs is a subcutaneously administered vaccine comprised of immune stimulatory peptides resembling cancer stem cell specific proteins.(Patent Title : Stimulation of Immunity to Tumor Stem Cell Specific Proteins by Peptide Immunization)

http://www.marketwired.com/press-release/therapeutic-solutions-international-announces-filing-new-immunotherapy-patent-exclusive-otc-pink-tsoi-2208787.htm

Cancer Metabolic Detox is an orally administered all natural nutraceutical product that is comprised of various herbal ingredients which seek to selectively block the cancer associated metabolic pathway that degrades the amino acid tryptophan.(Patent Title: Targeting the Tumor Microenvironment through Nutraceutical Based Immunoadjuvants)

http://www.marketwired.com/press-release/therapeutic-solutions-files-new-patent-on-targeting-tumor-microenvironment-through-nutraceutical-otc-pink-tsoi-2215015.htm

innaMune is a biological product derived from tissue culture of blood cells derived from healthy donors. It is a combination of cytokines that maintain activity of innate immune system cells, as well as having ability to shift M2 macrophages to M1.(Patent title: Activated Leukocyte Extract for Repair of Innate Immunity in Cancer Patients)

http://www.marketwired.com/press-release/therapeutic-solutions-files-patent-on-blood-derived-innate-immune-system-stimulator-otc-pink-tsoi-2216672.htm

LymphoBoost is a proprietary formulation of Mifepristone, a drug approved for another indication, which we have shown to be capable of stimulating lymphocytes, particularly NK cells and T cells, both critical in maintaining anti-tumor immunity.(Patent title: Augmentation of Anti-Tumor Immunity by Mifepristone and Analogues Thereof)

http://www.marketwired.com/press-release/therapeutic-solutions-files-new-patent-on-augmentation-anti-tumor-immunity-mifepristone-otc-pink-tsoi-2217703.htm

MemoryMune is a product derived from a two-step culture process of donor blood cells. The product reawakens dormant immune memory cells. It is known that many cancer patients possess memory T cells that enter the tumor, however, once inside the tumor these cells are inactivated. MemoryMune contains a unique combination of growth factors specific for immune system cells called “cytokines”.
(Patent title: Methods of Re-Activating Dormant Memory Cells with Anticancer Activity)

http://www.marketwired.com/press-release/therapeutic-solutions-files-patent-on-methods-re-activating-dormant-memory-cells-with-otc-pink-tsoi-2220094.htm